Search Results

59 Results for "angiochem".

Sort By

Deals

Hong Kong’s Xinogen Acquires China Rights to Angiochem Cancer Drug

Xinogen will make upfront and milestone payments and also pay royalties on sales, though specific details were not disclosed.

January 4, 2018
·
1 min read
Drug Development

AngioChem Reports Positive Clinical Data With ANG1005 In Breast Cancer Patients With Leptomeningeal Carcinomatosis

November 20, 2015
·
3 min read
AngioChem’s ANG1005 For Primary Brain Cancer And Brain Metastasis Selected As A Top 10 Project To Watch

November 12, 2013
·
1 min read
Preclinical Data On AngioChem Pain Program Published In Journal Of Clinical Investigation

February 18, 2014
·
1 min read
AngioChem To Present Clinical Data At The American Society of Clinical Oncology 2014 Annual Meeting

May 15, 2014
·
1 min read
AngioChem to Present at the American Society of Human Genetics 2013 Annual Meeting

October 17, 2013
·
1 min read
Business

Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer

Starlight Therapeutics today announced that Marc Chamberlain, M.D. has joined Starlight as its Chief Medical Officer.

January 17, 2024
·
8 min read
AngioChem Publishes Data On ANG4043, A Brain-Penetrant Anti-HER2 Monoclonal Antibody For Treatment Of Brain Metastases

December 9, 2014
·
3 min read
AngioChem Announces Presentations at Six Upcoming Conferences

September 26, 2012
·
1 min read
Drug Development

ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients With Brain Metastasis At The 2015 American Society For Clinical Oncology Annual Meeting

June 1, 2015
·
3 min read